A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT03536884 · COMPLETED
Trial details
- NCT number
- NCT03536884
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2019-09-12
- Enrollment
- 743
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.